Myles David C.

Track

Insider profile

Performance

Overall performance
4.1
Performance over holding periods
4.1
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Myles David C.'s trades of Olema Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-14 2026-01-14
PrS Proposed sale
24,216
204.72
US$3,503,210 		24,216 204.72 US$3,503,210
2026-01-14 2026-01-14
S Sale
17,887 -42.2%
92.32
US$4,710,010 		17,887 -42.2% 92.32 US$4,710,010
2026-01-14 2026-01-14
S Sale
52,618 +29.5%
131.84
US$2,722,869 		52,618 +29.5% 131.84 US$2,722,869
2026-01-14 2026-01-13
S Sale
200 -0.0%
28.49
US$5,698 		200 -0.0% 28.49 US$5,698
2026-01-14 2026-01-13
S Sale
49,800 -8.4%
27.60
US$1,374,480 		49,800 -8.4% 27.60 US$1,374,480
2026-01-13 2026-01-13
PrS Proposed sale
50,000
27.60
US$1,380,113 		50,000 27.60 US$1,380,113
2026-01-14 2026-01-12
S Sale
10,000 -6.5%
28.34
US$283,400 		10,000 -6.5% 28.34 US$283,400
2026-01-12 2026-01-12
PrS Proposed sale
10,000
28.34
US$283,363 		10,000 28.34 US$283,363
2025-12-23 2025-12-19
S Sale
6,046 -1.1%
31.39
US$189,784 		6,046 -1.1% 31.39 US$189,784
2025-12-23 2025-12-19
S Sale
43,729 -7.3%
30.40
US$1,329,362 		43,729 -7.3% 30.40 US$1,329,362
2025-12-23 2025-12-19
PlS Planned sale
1,225 -0.2%
28.08
US$34,398 		1,225 -0.2% 28.08 US$34,398
2025-12-19 2025-12-19
PrS Proposed sale
51,000
30.46
US$1,553,447 		51,000 30.46 US$1,553,447
2024-12-11 2024-12-11
PrS Proposed sale
13,614
8.68
US$118,180 		13,614 8.68 US$118,180
2024-12-11 2024-12-11
S Sale
300 -0.1%
9.39
US$2,817 		300 -0.1% 9.39 US$2,817
2024-12-11 2024-12-11
S Sale
13,314 -2.2%
8.66
US$115,299 		13,314 -2.2% 8.66 US$115,299
2024-12-11 2024-12-10
S Sale
12,452 -2.0%
9.38
US$116,800 		12,452 -2.0% 9.38 US$116,800
2024-12-10 2024-12-10
PrS Proposed sale
12,452
9.38
US$116,748 		12,452 9.38 US$116,748
2023-11-22 2023-11-22
PrS Proposed sale
6,653
13.89
US$92,421 		6,653 13.89 US$92,421
2023-11-22 2023-11-22
S Sale
6,653 -1.1%
13.89
US$92,410 		6,653 -1.1% 13.89 US$92,410
2023-11-22 2023-11-21
S Sale
200 -0.0%
15.32
US$3,064 		200 -0.0% 15.32 US$3,064
2023-11-22 2023-11-21
S Sale
6,776 -1.2%
14.87
US$100,759 		6,776 -1.2% 14.87 US$100,759
2023-11-21 2023-11-21
PrS Proposed sale
6,976
14.88
US$103,806 		6,976 14.88 US$103,806
2023-11-13 2023-11-08
PlS Planned sale
200 -0.0%
17.61
US$3,522 		200 -0.0% 17.61 US$3,522
2023-11-08 2023-11-08
PrS Proposed sale
200
17.61
US$3,521 		200 17.61 US$3,521
2023-11-03 2023-11-03
PrS Proposed sale
541
17.51
US$9,474 		541 17.51 US$9,474
2023-11-03 2023-11-03
PlS Planned sale
541 -0.1%
17.51
US$9,473 		541 -0.1% 17.51 US$9,473
2023-11-03 2023-11-02
PlS Planned sale
3,332 -0.6%
15.36
US$51,180 		3,332 -0.6% 15.36 US$51,180
2023-11-02 2023-11-02
PrS Proposed sale
3,332
15.36
US$51,176 		3,332 15.36 US$51,176
2023-11-03 2023-11-01
PlS Planned sale
6,668 -1.2%
15.02
US$100,153 		6,668 -1.2% 15.02 US$100,153
2023-11-01 2023-11-01
PrS Proposed sale
6,668
15.02
US$100,126 		6,668 15.02 US$100,126
2023-09-21 2023-09-19
PlS Planned sale
20,000 -3.4%
12.67
US$253,400 		20,000 -3.4% 12.67 US$253,400
2023-09-19 2023-09-19
PrS Proposed sale
20,000
12.67
US$253,400 		20,000 12.67 US$253,400
2021-12-14 2021-12-10
PlS Planned sale
10,000 -1.7%
10.30
US$103,000 		10,000 -1.7% 10.30 US$103,000